Corporate Update: Surgery Partners, Inc. (SGRY) and Peer Activity
Surgery Partners, Inc. (SGRY) advanced 3.25 % over the 24‑hour period concluding at 10:36 PM Central Europe on Friday, 23 October 2026. The stock is currently priced at approximately USD 15.75 on major exchanges. With a circulating supply of 130.9 million shares, the company’s market capitalization stands at USD 2.1 billion. In the last 24 hours, roughly USD 46.2 million worth of Surgery shares changed hands. Since the close of the previous month, Surgery’s share price has risen 9.2 %. The 200‑day simple moving average sits at USD 14.44, while the 52‑week high and low are USD 23.44 (29 October 2025) and USD 11.41 (30 March 2026), respectively.
Peer Movements in the Last 24 Hours
| Ticker | Change | Current Price | Market Cap | P/E | Recent News |
|---|---|---|---|---|---|
| Adeia (ADEA) | +5.92 % | USD 21.21 | USD 2.5 bn | 20.85 | Two senior officers filed Form 4 reports on 21 October 2026, acquiring additional shares. |
| Adma Biologics (ADMA) | –0.54 % | USD 10.68 | USD 2.5 bn | 15.62 | – |
| Euronet Worldwide (EEFT) | +1.73 % | USD 65.59 | USD 2.5 bn | 10.37 | Launched OLON, a unified commerce ecosystem targeting merchants in Greece and later Europe. |
| Guardian Pharmacy Services (GRDN) | –6.90 % | USD 39.44 | USD 2.5 bn | – | – |
| Banner (BANR) | +3.01 % | USD 70.28 | USD 2.5 bn | 11.23 | Reported Q3 2026 results; net income slightly lower due to merger expenses; declared dividend of USD 0.52 per share. |
Adeia (ADEA)
Adeia’s upward movement follows the disclosure of insider transactions by its Chief Licensing Officer, Kokes Mark, and Chief Legal Officer, Kevin Tanji, who each increased their holdings on 19 October 2026. The shares were withheld to satisfy tax‑withholding obligations linked to vesting releases, indicating continued executive confidence in the company’s trajectory.
Adma Biologics (ADMA)
Adma’s marginal decline keeps its valuation close to the 200‑day average, suggesting a stable but unremarkable performance in a sector dominated by biotechnology innovation.
Euronet Worldwide (EEFT)
Euronet’s modest gain accompanies the announcement of OLON, a next‑generation unified commerce platform. By integrating payment technology, business applications, and value‑added services, OLON aims to streamline merchant operations across physical, digital, and local payment channels. The initial rollout in Greece will involve hundreds of thousands of merchants, with plans to expand throughout Europe. This initiative positions Euronet to capture new revenue streams and deepen customer loyalty.
Guardian Pharmacy Services (GRDN)
Guardian’s sharp decline reflects broader market volatility in the pharmacy services space, where competition and regulatory pressures often create short‑term headwinds.
Banner (BANR)
Banner’s slight rise follows the disclosure of its third‑quarter 2026 earnings, which showed modest net income erosion due to merger‑related costs but maintained a solid earnings base. The company’s acquisition of Pacific Financial Corporation expanded its asset base, while its dividend declaration signals ongoing shareholder value creation.
About Surgery Partners, Inc.
Surgery Partners, Inc. is a healthcare services enterprise that owns and operates surgical facilities, physician‑partnered hospitals, and diagnostic laboratories across the United States. In addition to surgical care, the company offers anesthesia, pharmacy, ancillary, and optical services, positioning itself as a comprehensive provider of peri‑operative care. Its diversified portfolio and integrated service model underpin its market presence in a sector where efficiency and patient experience are paramount.
